Purple Biotech (PPBT) Invested Capital (2015 - 2017)

Purple Biotech (PPBT) has reported Invested Capital for 3 consecutive years, with $3.0 million the latest figure, recorded in Q4 2017.

• In Q4 2017, Invested Capital rose 455.11% year-over-year to $3.0 million; the TTM figure through Jun 2019 stood at $3.0 million (down 15.26% YoY), while the FY2017 annual figure was $3.0 million, up 455.11% from the prior year.
• Invested Capital climbed to $3.0 million in Q4 2017 per PPBT's latest filing, from $548000.0 in the prior quarter.
• Across five years, Invested Capital topped out at $3.0 million in Q4 2017 and bottomed at $548000.0 in Q4 2016.
• Historically, Invested Capital has averaged $1.4 million across 3 years, with a median of $549000.0 in 2015.
• Annual changes were most pronounced in 2016 — Invested Capital fell 0.18% — and 2017, when it soared 455.11%.
• Purple Biotech's Invested Capital stood at $549000.0 in 2015, then declined by 0.18% to $548000.0 in 2016, then jumped by 455.11% to $3.0 million in 2017.
• Business Quant data shows PPBT's Invested Capital at $3.0 million in Q4 2017, $548000.0 in Q4 2016, and $549000.0 in Q4 2015.